Meningitis vaccines could help tackle untreatable gonorrhoea
13 April, 2022Latest studies from South Australia and the US have indicated that meningitis vaccines could help improve protection against gonorrhoea.
UTIs are becoming more deadly, thanks to AMR — CSIRO
06 April, 2022The spread of drug-resistant bacteria in the community is increasing the risk of death for common infections such as urinary tract infections (UTIs) — which affect around one in two women and one in 20 men in their lifetime.
How can air purifiers help aged care facilities protect residents and staff from harmful viruses?
28 March, 2022 by Kate Smith, Head of Clinical Solutions, Training and Support – GAMA Healthcare (RN/RM, GCertNurs, Cert IV TAE)As winter approaches, with its associated colds and flu, many aged care and long term care facilities will be looking for additional methods to protect their residents and staff.
COVID-19 taskforce publishes new risk classification tool
21 March, 2022The National COVID-19 Clinical Evidence Taskforce (NCCET) has developed a risk classification tool to guide clinicians making decisions about which people are most likely to benefit from drugs.
How antimicrobial resistance spreads inside the human gut
21 March, 2022A collaboration between the Hudson Institute of Medical Research and the Wellcome Sanger Institute, Cambridge UK, explores how antimicrobial resistance (AMR) spreads inside the human gut.
Shingrix approved for Australians 18+ at high risk
14 March, 2022GSK Australia's Shingrix is available on the private market for the prevention of shingles and post-herpetic neuralgia in people aged 18 years and over who are at increased risk of shingles.
2022 influenza control: virologist recommends four actions
09 March, 2022With the lifting of border restrictions and quarantine regulations, Australians can anticipate the reintroduction of influenza, according to the authors of an editorial published by the Medical Journal of Australia.
Mild COVID-19 linked to changes in brain structure: study
09 March, 2022New research reveals the damaging effects of COVID-19 and improves our understanding of how the disease spreads through the central nervous system.
Hepatitis B: new recommendations for clinicians
07 March, 2022New recommendations for the management of hepatitis B have been released in a bid to improve awareness of chronic hepatitis B among clinicians and to increase detection of cases that currently remain undiagnosed.
COVID-19 antiviral available on the PBS
02 March, 2022Australians at risk of progressing to severe COVID-19 disease will now be eligible to access an oral antiviral treatment through the PBS.
Ultrasound infection prevention workflow: standardisation unlocking risk management
01 March, 2022Discover how Nanosonics AuditPro can standardise your ultrasound IP practices.
Global trial to investigate fractional COVID-19 boosters
23 February, 2022Up to 3300 healthy adults across Australia, Indonesia and Mongolia will be invited to take part in a global trial investigating the impact of administering reduced COVID-19 booster shots.
Scoping study for mRNA vaccine nasal spray begins
10 February, 2022Macquarie University respiratory scientist Professor Daniela Traini and Professor Pall Thordarson, Director of the UNSW RNA Institute, have started work on a scoping study to deliver mRNA vaccines via nasal spray.
Staff scarcity hits hard. How are safety compliance solutions relieving the pressure?
01 February, 2022From the early hours of 2022, healthcare teams braced themselves for a new wave of challenges.
ACT Health uses GS1 standards to support innovative solutions in the fight against Covid-19
01 February, 2022For more than 13 years, ACT Health has been on the forefront of implementing and using GS1 standards, integrating standards into many of its business and clinical processes.
